Dexa Group

dexagroup logo desktop hut 54 dexa en

Move Together, Grab Opportunities

For more than five decades, Dexa Group has been committed to the promotion of health through the safety, quality, and efficacy of medicinal products.

From Molecule, to Market

Building end-to-end competency in pharmaceutical discovery, formulation, manufacturing, and marketing across four continents: Asia, Africa, Europe, and America.

Dexa means Quality

Our name was inspired by the Greek δέκα, meaning 10 — a universal symbol of perfection. Even today, our work aspires to that same impossible standard. That’s why, for millions of people in 14 countries, Dexa means quality.

Indonesian Modern Herbal Medicines

We identify, extract, and test biomolecules embedded deep in nature. Then, we use these microscopic gems to produce herbal medicines that are extraordinarily safe and effective.

Dexa: A Snapshot




Pharmacies Covered Directly

International Alliances

Marketing Authorisations

Latest News

1 November 2023

Dexa Group Partners Up with BPOM to Reach Net Zero Emission

Dexa Group participates in supporting collaboration between the Indonesian Food and Drug Authority (BPOM) and business actors for the Net Zero Carbon Program through planting mangroves in the Angke Nature Tourism Park (TWAA) Kapuk area, Jakarta, on Tuesday, 31 October 2023. This program implements the Sustainable Development Goals (SDG) and…
28 October 2023

Stunting Rate Reaches 34,9%, Dexa Medica Collaborates with BKKBN in Educating Hundreds of Midwives in Jember

In the 2024 State Budget and Revenue (APBN), President Joko Widodo allocated IDR 186.4 trillion or 5.6 percent for the health sector. One of the primary goals is to reduce the prevalence of stunting in Indonesia to 14 percent by 2024. To accelerate the stunting reduction target of 14 percent…
28 October 2023

Prof. Raymond Tjandrawinata, a Pioneer of Indonesian Indigenous Modern Medicine Provides Education in Stunting Prevention

The 2022 Indonesian Nutrition Status Survey (SSGI) reported that the prevalence of stunting in Jember reached 34.9%, the highest in East Java. Pharmacologist Prof. Raymond R. Tjandrawinata provided education at the Education on Stunting Intervention for Midwives program in Jember Regency to accelerate the stunting reduction to 14% by 2024…
23 October 2023

Dexa Group Continues Participating in the Global Market by Attending the 38th Trade Expo Indonesia

Dexa Group participated at the 38th Trade Expo Indonesia as a sign of commitment and continuity in the export industry. Dexa Group took part by setting up a booth with top export products such as Indonesia Indigenous Modern Medicine (OMAI), Boska, and Glucient SR. Mrs. Gracianti Soetikno, Commissioner of Dexa Group,…
11 September 2023

Dexa Medica and the Indonesian National Army (TNI AD) Collaborate to Reduce Stunting

Dexa Medica continues collaborating with diverse stakeholders to play an active role in the program to reduce stunting to 14% by 2024. Dexa Medica collaborated with the Indonesian National Army (TNI AD) and the Family Coordinating Agency National Planning (BKKBN) on this occasion to launch the e-Stuntad and e-Posyandu apps…
6 September 2023

Dexa Medica Halal Product Guarantee System Wins Halal Award

Dexa Group once again received the Halal Award from the Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia (LPPOM MUI) in the Best Social Contribution on Halal environment category, demonstrating its dedication to establishing a halal environment in Indonesia. "I congratulate all companies and business actors nominated for and…